Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000 Aug;6(8):916-9. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. A critical initial study for validating immunotherapy of AD.

    View all comments by Yungfeng Liao

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Fatal Attraction or Beneficial Interaction: Microglia, Aβ and Neurons
  2. Antibodies Stop Toxic Tau in Its Extracellular Tracks

Research Timeline Event

  1. First Aβ active immunotherapy in mice